11/19
09:14 am
govx
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia [Yahoo! Finance]
Low
Report
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia [Yahoo! Finance]
11/19
09:00 am
govx
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Low
Report
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
11/15
08:04 am
govx
GeoVax Labs, Inc. (NASDAQ: GOVX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
GeoVax Labs, Inc. (NASDAQ: GOVX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
11/13
02:26 am
govx
Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges [Yahoo! Finance]
Medium
Report
Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges [Yahoo! Finance]
11/12
04:00 pm
govx
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
High
Report
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
11/12
08:18 am
govx
GeoVax Labs initiated with a Buy at Alliance Global Partners [Yahoo! Finance]
Medium
Report
GeoVax Labs initiated with a Buy at Alliance Global Partners [Yahoo! Finance]
11/11
07:47 am
govx
GeoVax Labs, Inc. (NASDAQ: GOVX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $15.00 price target on the stock.
High
Report
GeoVax Labs, Inc. (NASDAQ: GOVX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $15.00 price target on the stock.
11/5
09:00 am
govx
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
Low
Report
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
10/2
09:00 am
govx
GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Medium
Report
GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
9/4
12:00 am
govx
GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move [Yahoo! Finance]
High
Report
GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move [Yahoo! Finance]
9/3
09:00 am
govx
GeoVax to Participate in Upcoming Investor Conferences in September
Low
Report
GeoVax to Participate in Upcoming Investor Conferences in September
8/28
08:59 pm
govx
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
Medium
Report
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
8/28
04:25 pm
govx
EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding [Yahoo! Finance]
Medium
Report
EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding [Yahoo! Finance]
8/27
11:17 am
govx
Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross? [Yahoo! Finance]
Low
Report
Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross? [Yahoo! Finance]
8/26
12:28 pm
govx
Tonix stock jumps on collaboration for mpox vaccine candidate [Seeking Alpha]
Medium
Report
Tonix stock jumps on collaboration for mpox vaccine candidate [Seeking Alpha]